Reactions Weekly

, Volume 1697, Issue 1, pp 142–142 | Cite as

Dasatinib/imatinib/nilotinib

Developement of drug resistance: case report
Case report
  • 16 Downloads

Reference

  1. Okada Y, et al. Sudden blast phase in chronic myeloid leukemia developed during nilotinib therapy after major molecular response was achieved. International Journal of Hematology 107: 495-497, No. 4, Apr 2018. Available from: URL: http://doi.org/10.1007/s12185-017-2354-6 - JapanCrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations